| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.034 | 0.5 |